Other
Fibrotouch
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Other(3)
Detailed Status
unknown3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Trials by Status
unknown3100%
Recent Activity
0 active trials
Showing 3 of 3
unknown
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
NCT05421572
unknown
Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes
NCT03525769
unknown
Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
NCT02456766
Clinical Trials (3)
Showing 3 of 3 trials
NCT05421572
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
NCT03525769
Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes
NCT02456766
Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3